Literature DB >> 22100625

Optimizing reliability and sensitivity of Semmes-Weinstein monofilaments for establishing point tactile thresholds.

Elisabeth H Tracey1, Aaron J Greene, Richard L Doty.   

Abstract

Semmes-Weinstein monofilaments (SWM) are widely used to assess tactile point pressure sensitivity. However, the reliability of SWMs has been questioned, standardization of stimulus presentation procedures is lacking, and the sensitivity measure is commonly confounded by the response criterion. This study sought to assess the reliability of two versions of a forced-choice single staircase SWM test with the goal of optimizing test reliability with a minimum number of test trials. Test-retest and intra-test reliability coefficients for SWM threshold values from the plantar halluces of 24 normal subjects were obtained using two versions of a forced-choice single-staircase procedure. One version followed a two-down one-up rule (2D) and the other a three-down one-up rule (3D). The 3D procedure was significantly more reliable than the 2D procedure for all sequential combinations of reversal pairs. A total of four 3D reversal pairs (i.e., eight reversals) were sufficient to achieve test-retest and intra-test reliability coefficients>0.90. High reliability with the minimum number of trials was obtained by calculating the threshold as the mean of eight reversals (test-retest r=0.93, p<0.001; Sessions 1 and 2 intra-test rs=0.87 and 0.92; ps<0.001). Identical median detection thresholds were noted for the two repeated test sessions (5.1g/mm(2)). The threshold values correlated with subject age despite the small range of ages tested, suggesting high sensitivity (Sessions 1 and 2 rs=0.61 and 0.63, ps<0.001). This study demonstrates that SWMs provide highly reliable and sensitive point pressure thresholds with very few trials when an appropriate psychophysical paradigm is employed. The brief forced-choice procedure described herein could serve as a basis for standardizing SWM stimulus presentation methods.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22100625     DOI: 10.1016/j.physbeh.2011.11.002

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  7 in total

1.  Vestibular labyrinth contributions to human whole-body motion discrimination.

Authors:  Yulia Valko; Richard F Lewis; Adrian J Priesol; Daniel M Merfeld
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

2.  Force Perception Thresholds in Cochlear Implantation Surgery.

Authors:  Louis B Kratchman; Daniel Schuster; Mary S Dietrich; Robert F Labadie
Journal:  Audiol Neurootol       Date:  2016-08-30       Impact factor: 1.854

3.  Predicting Improved Daily Use of the More Affected Arm Poststroke Following Constraint-Induced Movement Therapy.

Authors:  Mohammad H Rafiei; Kristina M Kelly; Alexandra L Borstad; Hojjat Adeli; Lynne V Gauthier
Journal:  Phys Ther       Date:  2019-12-16

4.  A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes.

Authors:  Jennifer J Brown; Shana L Pribesh; Kimberly G Baskette; Aaron I Vinik; Sheri R Colberg
Journal:  J Diabetes Res       Date:  2017-11-08       Impact factor: 4.011

5.  Oral somatosensatory acuity is related to particle size perception in chocolate.

Authors:  Scott P Breen; Nicole M Etter; Gregory R Ziegler; John E Hayes
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

6.  Upper limb sensory evaluations and ultrasonographic skin measurements in breast cancer-related lymphedema receiving complex decongestive physiotherapy.

Authors:  Emine Baran; Levent Özçakar; Serap Özgül; Sercan Aksoy; Türkan Akbayrak
Journal:  Support Care Cancer       Date:  2021-04-29       Impact factor: 3.603

7.  Sensory Stimulation of the Foot and Ankle Early Post-stroke: A Pilot and Feasibility Study.

Authors:  Alison M Aries; Valerie M Pomeroy; Julius Sim; Susan Read; Susan M Hunter
Journal:  Front Neurol       Date:  2021-07-05       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.